+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Risk factors for breast cancer according to estrogen and progesterone receptor status



Risk factors for breast cancer according to estrogen and progesterone receptor status



Journal of the National Cancer Institute 96(3): 218-228



Background: Evaluations of epidemiologic risk factors in relation to breast cancer classified jointly by estrogen receptor (ER) and progesterone receptor (PR) status have been inconsistent. To address this issue, we conducted a prospective evaluation of risk factors for breast cancer classified according to receptor status. Methods: During 1 029 414 person-years of follow-up of 66 145 women participating in the Nurses' Health Study from 1980 through 2000, we identified 2096 incident cases of breast cancer for which information on ER/PR status was available: 1281 were ER+/PR+, 318 were ER+/PR-, 80 were ER-/PR+, and 417 were ER-/PR-. We fit a log-incidence model of breast cancer and used polychotomous logistic regression to compare coefficients for breast cancer risk factors in patients with different ER/PR status. To test for differences in risk factor odds ratios based on marginal ER/PR categories, we evaluated ER status controlling for PR status and vice versa. The predictive ability of our log-incidence model to discriminate between women who would develop ER+/PR+ breast cancer and those who would not (and similarly for ER-/PR- breast cancer) was evaluated by using receiver operator characteristic curve analysis. All statistical tests were two-sided. Results: We observed statistically significant heterogeneity among the four ER/PR categories for some risk factors (age, menopausal status, body mass index (BMI) after menopause, the one-time adverse effect of first pregnancy, and past use of postmenopausal hormones) but not for others (benign breast disease, family history of breast cancer, alcohol use, and height). The one-time adverse association of first pregnancy with incidence was present for PR- but not for PR+ tumors after controlling for ER status (P=.007). However, the association of BMI after menopause with incidence was present for PR+ but not PR- tumors (P=.005). Statistically significant differences in the incidence of ER+ and ER- tumors were seen with age, both before and after menopause (P=.003), and with past use of postmenopausal hormones (P=.01). Area under the receiver operator characteristic curve, adjusted for age, was 0.64 (95% confidence interval (CI)=0.63 to 0.66) for ER+/PR+ tumors and 0.61 (95% CI=0.58 to 0.64) for ER-/PR- tumors. Conclusions: Incidence rates and risk factors for breast cancer differ according to ER and PR status. Thus, to accurately estimate breast cancer risk, breast cancer cases should be divided according to the ER and PR status of the tumor.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 012521172

Download citation: RISBibTeXText

PMID: 14759989

DOI: 10.1093/jnci/djh025


Related references

Differences in breast cancer risk factors by estrogen and progesterone receptor status. American Journal of Epidemiology 143(11 Suppl. ): S33, 1996

Breast cancer risk factors according to joint estrogen receptor and progesterone receptor status. Cancer Detection and Prevention 29(5): 419-426, 2005

Hormone-related factors and risk of breast cancer by estrogen receptor and progesterone receptor status. American Journal of Epidemiology 147(11 Suppl. ): S35, 1998

Hormone-related Factors and Risk of Breast Cancer in Relation to Estrogen Receptor and Progesterone Receptor Status. American Journal of Epidemiology 151(7): 703-714, 2000

Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. American Journal of Epidemiology 151(7): 703-714, 2000

Risk factors for postmenopausal breast cancer differ according to joint estrogen and progesterone receptor status. Proceedings of the American Association for Cancer Research Annual Meeting 34: 264, 1993

Differences in breast cancer risk factors according to estrogen and progesterone receptor status Case-control analysis. Breast Cancer Research & Treatment 37(Suppl. ): 97, 1996

Breast cancer risk factors according to combined estrogen and progesterone receptor status: a case-control analysis. American Journal of Epidemiology 146(4): 307-314, 1997

Breast cancer risk factors defined by estrogen and progesterone receptor status: the multiethnic cohort study. American Journal of Epidemiology 169(10): 1251-1259, 2009

A Hospital-Based Case-Control Study of Breast-Cancer Risk Factors by Estrogen and Progesterone Receptor Status. Cancer Causes & Control 4(1): 39-44, 1993

A hospital-based case-control study of breast-cancer risk factors by estrogen and progesterone receptor status. Cancer Causes & Control. 4(1): 39-44, 1993

Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Breast Cancer Research 8(4): R43, 2006

Association of hormone-related characteristics and breast cancer risk by estrogen receptor/progesterone receptor status in the shanghai breast cancer study. American Journal of Epidemiology 174(6): 661-671, 2011

Relation between receptor status and ultrastructure in breast cancer estrogen and progesterone receptor positive vs. estrogen and progesterone receptor negative. Pathology Research and Practice 181(4): 377-381, 1986

Risk of breast cancer classified by joint estrogen receptor and progesterone receptor status among women 20-44 years of age. American Journal of Epidemiology 156(6): 507-516, 2002